T5O Stock Chart & Stats
€1.11
-€0.06(-4.35%)
At close: 4:00 PM EST
€1.11
-€0.06(-4.35%)
Day’s Range― - ―
52-Week Range€0.06 - €3.05
Previous CloseN/A
VolumeN/A
Average Volume (3M)218.00
Market Cap
€143.80K
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.80
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding271,865
10 Day Avg. Volume601
30 Day Avg. Volume218
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
T5O FAQ
What was CytoTools AG’s price range in the past 12 months?
CytoTools AG lowest stock price was €0.06 and its highest was €3.05 in the past 12 months.
What is CytoTools AG’s market cap?
CytoTools AG’s market cap is €143.80K.
When is CytoTools AG’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were CytoTools AG’s earnings last quarter?
Currently, no data Available
Is CytoTools AG overvalued?
According to Wall Street analysts CytoTools AG’s price is currently Overvalued.
Does CytoTools AG pay dividends?
CytoTools AG does not currently pay dividends.
What is CytoTools AG’s EPS estimate?
CytoTools AG’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does CytoTools AG have?
CytoTools AG has 271,865 shares outstanding.
What happened to CytoTools AG’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of CytoTools AG?
Currently, no hedge funds are holding shares in DE:T5O
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CytoTools AG Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Company Description
CytoTools AG
CytoTools AG is an investment and holding company in the technology sector. It originated from CytoTools GmbH, a successful German technology enterprise from the pharmaceuticals and medical products field.
Technical Analysis
―
B.R.A.I.N. Biotechnology Research and Information Network
―
Medigene
―
Heidelberg Pharma AG
―
Formycon AG
―